{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T18:57:34Z","timestamp":1769885854294,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00259-025-07603-6","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T06:49:10Z","timestamp":1760510950000},"page":"1856-1868","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["18F-FDG PET\/CT and contrast-enhanced CT evaluation of lymph node status after neoadjuvant immunochemotherapy in patients with esophageal squamous cell carcinoma"],"prefix":"10.1007","volume":"53","author":[{"given":"Yuhong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianhong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangsong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3571-8154","authenticated-orcid":false,"given":"Chao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8633-1825","authenticated-orcid":false,"given":"Xiaoyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"7603_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"key":"7603_CR2","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/s0140-6736(24)02226-8","volume":"404","author":"H Yang","year":"2024","unstructured":"Yang H, Wang F, Hallemeier CL, Lerut T, Fu J. Oesophageal cancer. Lancet. 2024;404:1991\u20132005. https:\/\/doi.org\/10.1016\/s0140-6736(24)02226-8.","journal-title":"Lancet"},{"key":"7603_CR3","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1038\/s41591-024-03064-w","volume":"30","author":"J Qin","year":"2024","unstructured":"Qin J, Xue L, Hao A, Guo X, Jiang T, Ni Y, et al. Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO\/NCCES01 trial. Nat Med. 2024;30:2549\u201357. https:\/\/doi.org\/10.1038\/s41591-024-03064-w.","journal-title":"Nat Med"},{"key":"7603_CR4","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1001\/jama.2021.12836","volume":"326","author":"H Luo","year":"2021","unstructured":"Luo H, Lu J, Bai Y, Mao T, Wang J, Fan Q, et al. Effect of camrelizumab vs placebo added to chemotherapy on survival and progression-free survival in patients with advanced or metastatic esophageal squamous cell carcinoma: the ESCORT-1st randomized clinical trial. JAMA. 2021;326:916\u201325. https:\/\/doi.org\/10.1001\/jama.2021.12836.","journal-title":"JAMA"},{"issue":"1","key":"7603_CR5","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1097\/js9.0000000000002011","volume":"111","author":"K Lan","year":"2025","unstructured":"Lan K, Yan X, Lei J, Guo X, Zhou Y, Wang X, et al. Clinical outcomes and short-term survival of neoadjuvant immunochemotherapy for resectable esophageal cancer: a multicenter retrospective cohort study. Int J Surg. 2025;111(1):1547\u201351. https:\/\/doi.org\/10.1097\/js9.0000000000002011.","journal-title":"Int J Surg"},{"key":"7603_CR6","doi-asserted-by":"publisher","first-page":"1052542","DOI":"10.3389\/fimmu.2022.1052542","volume":"13","author":"L Xu","year":"2022","unstructured":"Xu L, Wei XF, Li CJ, Yang ZY, Yu YK, Li HM, et al. Pathologic responses and surgical outcomes after neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma. Front Immunol. 2022;13:1052542. https:\/\/doi.org\/10.3389\/fimmu.2022.1052542.","journal-title":"Front Immunol"},{"key":"7603_CR7","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1097\/sla.0000000000004238","volume":"275","author":"T Hagi","year":"2022","unstructured":"Hagi T, Makino T, Yamasaki M, Yamashita K, Tanaka K, Saito T, et al. Pathological regression of lymph nodes better predicts long-term survival in esophageal cancer patients undergoing neoadjuvant chemotherapy followed by surgery. Ann Surg. 2022;275:1121\u20139. https:\/\/doi.org\/10.1097\/sla.0000000000004238.","journal-title":"Ann Surg"},{"key":"7603_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/sla.0000000000004798","volume":"277","author":"X Guo","year":"2023","unstructured":"Guo X, Wang Z, Yang H, Mao T, Chen Y, Zhu C, et al. Impact of lymph node dissection on survival after neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: from the results of NEOCRTEC5010, a randomized multicenter study. Ann Surg. 2023;277:259\u201366. https:\/\/doi.org\/10.1097\/sla.0000000000004798.","journal-title":"Ann Surg"},{"key":"7603_CR9","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1245\/s10434-020-09363-z","volume":"28","author":"PK Hsu","year":"2021","unstructured":"Hsu PK, Yeh YC, Chien LI, Huang CS, Hsu HS. Clinicopathological significance of pathologic complete lymph node regression after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma. Ann Surg Oncol. 2021;28:2048\u201358. https:\/\/doi.org\/10.1245\/s10434-020-09363-z.","journal-title":"Ann Surg Oncol"},{"key":"7603_CR10","doi-asserted-by":"publisher","first-page":"e1022","DOI":"10.1097\/sla.0000000000003727","volume":"274","author":"X Leng","year":"2021","unstructured":"Leng X, He W, Yang H, Chen Y, Zhu C, Fang W, et al. Prognostic impact of postoperative lymph node metastases after neoadjuvant chemoradiotherapy for locally advanced squamous cell carcinoma of esophagus: from the results of NEOCRTEC5010, a randomized multicenter study. Ann Surg. 2021;274:e1022\u20139. https:\/\/doi.org\/10.1097\/sla.0000000000003727.","journal-title":"Ann Surg"},{"key":"7603_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/sla.0000000000002824","volume":"269","author":"E Visser","year":"2019","unstructured":"Visser E, Markar SR, Ruurda JP, Hanna GB, van Hillegersberg R. Prognostic value of lymph node yield on overall survival in esophageal cancer patients: a systematic review and meta-analysis. Ann Surg. 2019;269:261\u20138. https:\/\/doi.org\/10.1097\/sla.0000000000002824.","journal-title":"Ann Surg"},{"key":"7603_CR12","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1097\/sla.0000000000003598","volume":"274","author":"S Raja","year":"2021","unstructured":"Raja S, Rice TW, Murthy SC, Ahmad U, Semple ME, Blackstone EH, et al. Value of lymphadenectomy in patients receiving neoadjuvant therapy for esophageal adenocarcinoma. Ann Surg. 2021;274:e320\u20137. https:\/\/doi.org\/10.1097\/sla.0000000000003598.","journal-title":"Ann Surg"},{"key":"7603_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.21037\/acs.2017.03.14","volume":"6","author":"TW Rice","year":"2017","unstructured":"Rice TW, Patil DT, Blackstone EH. 8th edition AJCC\/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothorac Surg. 2017;6:119\u201330. https:\/\/doi.org\/10.21037\/acs.2017.03.14.","journal-title":"Ann Cardiothorac Surg"},{"key":"7603_CR14","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.21037\/atm-20-4991","volume":"8","author":"B Li","year":"2020","unstructured":"Li B, Li B, Jiang H, Yang Y, Zhang X, Su Y, et al. The value of enhanced CT scanning for predicting lymph node metastasis along the right recurrent laryngeal nerve in esophageal squamous cell carcinoma. Ann Transl Med. 2020;8:1632. https:\/\/doi.org\/10.21037\/atm-20-4991.","journal-title":"Ann Transl Med"},{"key":"7603_CR15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s00330-017-4935-4","volume":"28","author":"J Liu","year":"2018","unstructured":"Liu J, Wang Z, Shao H, Qu D, Liu J, Yao L. Improving CT detection sensitivity for nodal metastases in oesophageal cancer with combination of smaller size and lymph node axial ratio. Eur Radiol. 2018;28:188\u201395. https:\/\/doi.org\/10.1007\/s00330-017-4935-4.","journal-title":"Eur Radiol"},{"key":"7603_CR16","doi-asserted-by":"publisher","first-page":"e0309653","DOI":"10.1371\/journal.pone.0309653","volume":"19","author":"X Sun","year":"2024","unstructured":"Sun X, Niwa T, Kazama T, Okazaki T, Koyanagi K, Kumaki N, et al. Preoperative dual-energy computed tomography and positron-emission tomography evaluation of lymph node metastasis in esophageal squamous cell carcinoma. PLoS ONE. 2024;19:e0309653. https:\/\/doi.org\/10.1371\/journal.pone.0309653.","journal-title":"PLoS ONE"},{"key":"7603_CR17","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2967\/jnumed.113.130716","volume":"55","author":"SH Moon","year":"2014","unstructured":"Moon SH, Kim HS, Hyun SH, Choi YS, Zo JI, Shim YM, et al. Prediction of occult lymph node metastasis by metabolic parameters in patients with clinically N0 esophageal squamous cell carcinoma. J Nucl Med. 2014;55:743\u20138. https:\/\/doi.org\/10.2967\/jnumed.113.130716.","journal-title":"J Nucl Med"},{"key":"7603_CR18","doi-asserted-by":"publisher","unstructured":"Japanese Classification of Esophageal Cancer, 11th Edition: part I. Esophagus. 2017;14:1\u201336. https:\/\/doi.org\/10.1007\/s10388-016-0551-7","DOI":"10.1007\/s10388-016-0551-7"},{"key":"7603_CR19","doi-asserted-by":"publisher","first-page":"7719","DOI":"10.7314\/apjcp.2014.15.18.7719","volume":"15","author":"R Tan","year":"2014","unstructured":"Tan R, Yao SZ, Huang ZQ, Li J, Li X, Tan HH, et al. Combination of FDG PET\/CT and contrast-enhanced MSCT in detecting lymph node metastasis of esophageal cancer. Asian Pac J Cancer Prev. 2014;15:7719\u201324. https:\/\/doi.org\/10.7314\/apjcp.2014.15.18.7719.","journal-title":"Asian Pac J Cancer Prev"},{"key":"7603_CR20","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/RLU.0b013e31823924bb","volume":"37","author":"M Kobayashi","year":"2012","unstructured":"Kobayashi M, Kaida H, Kawahara A, Hattori S, Kurata S, Hayakawa M, et al. The relationship between GLUT-1 and vascular endothelial growth factor expression and 18F-FDG uptake in esophageal squamous cell cancer patients. Clin Nucl Med. 2012;37:447\u201352. https:\/\/doi.org\/10.1097\/RLU.0b013e31823924bb.","journal-title":"Clin Nucl Med"},{"key":"7603_CR21","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.18632\/oncotarget.24684","volume":"10","author":"H Yang","year":"2019","unstructured":"Yang H, Zhong JT, Zhou SH, Han HM. Roles of GLUT-1 and HK-II expression in the biological behavior of head and neck cancer. Oncotarget. 2019;10:3066\u201383. https:\/\/doi.org\/10.18632\/oncotarget.24684.","journal-title":"Oncotarget"},{"key":"7603_CR22","doi-asserted-by":"publisher","first-page":"4241","DOI":"10.1007\/s00259-022-05872-z","volume":"49","author":"X Wang","year":"2022","unstructured":"Wang X, Yang W, Zhou Q, Luo H, Chen W, Yeung SJ, et al. The role of (18)F-FDG PET\/CT in predicting the pathological response to neoadjuvant PD-1 Blockade in combination with chemotherapy for resectable esophageal squamous cell carcinoma. Eur J Nucl Med Mol Imaging. 2022;49:4241\u201351. https:\/\/doi.org\/10.1007\/s00259-022-05872-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7603_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12149-008-0209-1","volume":"23","author":"M Okada","year":"2009","unstructured":"Okada M, Murakami T, Kumano S, Kuwabara M, Shimono T, Hosono M, et al. Integrated FDG-PET\/CT compared with intravenous contrast-enhanced CT for evaluation of metastatic regional lymph nodes in patients with resectable early stage esophageal cancer. Ann Nucl Med. 2009;23:73\u201380. https:\/\/doi.org\/10.1007\/s12149-008-0209-1.","journal-title":"Ann Nucl Med"},{"key":"7603_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00473","volume":"10","author":"J Nie","year":"2020","unstructured":"Nie J, Ling W, Yang Q, Jin H, Ou X, Ma X. The value of CEUS in distinguishing cancerous lymph nodes from the primary lymphoma of the head and neck. Front Oncol. 2020;10:473. https:\/\/doi.org\/10.3389\/fonc.2020.00473.","journal-title":"Front Oncol"},{"key":"7603_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01984","author":"SAC McDowell","year":"2019","unstructured":"McDowell SAC, Quail DF. Immunological regulation of vascular inflammation during cancer metastasis. Front Immunol. 2019. https:\/\/doi.org\/10.3389\/fimmu.2019.01984. 10:1984.","journal-title":"Front Immunol"},{"key":"7603_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/nyas.14462","volume":"1482","author":"X Zhang","year":"2020","unstructured":"Zhang X, Jain D. Updates in staging and pathologic evaluation of esophageal carcinoma following neoadjuvant therapy. Ann N Y Acad Sci. 2020;1482:163\u201376. https:\/\/doi.org\/10.1111\/nyas.14462.","journal-title":"Ann N Y Acad Sci"},{"key":"7603_CR27","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1093\/annonc\/mdy218","volume":"29","author":"TR Cottrell","year":"2018","unstructured":"Cottrell TR, Thompson ED, Forde PM, Stein JE, Duffield AS, Anagnostou V, et al. Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC). Ann Oncol. 2018;29:1853\u201360. https:\/\/doi.org\/10.1093\/annonc\/mdy218.","journal-title":"Ann Oncol"},{"key":"7603_CR28","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s00330-014-3373-9","volume":"25","author":"T Saito","year":"2015","unstructured":"Saito T, Kurokawa Y, Takiguchi S, Miyazaki Y, Takahashi T, Yamasaki M, et al. Accuracy of multidetector-row CT in diagnosing lymph node metastasis in patients with gastric cancer. Eur Radiol. 2015;25:368\u201374. https:\/\/doi.org\/10.1007\/s00330-014-3373-9.","journal-title":"Eur Radiol"},{"key":"7603_CR29","doi-asserted-by":"publisher","DOI":"10.21037\/atm-21-4926","volume":"9","author":"S Liao","year":"2021","unstructured":"Liao S, Wei W, Zhang S, Zeng T, Chen H, Zheng W, et al. Modified method to improve the diagnostic efficiency of (18)F-FDG PET\/CT in regional lymph node metastasis of esophageal squamous cell carcinoma. Ann Transl Med. 2021;9:1549. https:\/\/doi.org\/10.21037\/atm-21-4926.","journal-title":"Ann Transl Med"},{"key":"7603_CR30","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.3748\/wjg.14.1479","volume":"14","author":"SR Puli","year":"2008","unstructured":"Puli SR, Reddy JB, Bechtold ML, Antillon D, Ibdah JA, Antillon MR. Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systematic review. World J Gastroenterol. 2008;14:1479\u201390. https:\/\/doi.org\/10.3748\/wjg.14.1479.","journal-title":"World J Gastroenterol"},{"key":"7603_CR31","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1590\/1806-9282.64.02.170","volume":"64","author":"J Li","year":"2018","unstructured":"Li J, Chen S, Zhu G. Comparative study of computed tomography (CT) and pathological diagnosis toward mediastinal lymph node metastasis in esophageal carcinoma. Rev Assoc Med Bras (1992). 2018;64:170\u20134. https:\/\/doi.org\/10.1590\/1806-9282.64.02.170.","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"7603_CR32","doi-asserted-by":"publisher","first-page":"962","DOI":"10.3760\/cma.j.cn112152-20220313-00173","volume":"45","author":"ZX Li","year":"2023","unstructured":"Li ZX, Liu XB, Li Y, Liang GH, Wang ZF, Zheng Y, et al. [Application value of CT examination of lymph node short diameter in evaluating cardia-left gastric lymph node metastasis in thoracic esophageal squamous cell carcinoma]. Zhonghua Zhong Liu Za Zhi. 2023;45:962\u20136. https:\/\/doi.org\/10.3760\/cma.j.cn112152-20220313-00173.","journal-title":"Zhonghua Zhong Liu Za Zhi"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07603-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07603-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07603-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:43:09Z","timestamp":1769834589000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07603-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7603"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07603-6","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the First Affiliated Hospital of Sun Yat-sen University (approval ID:[2025]097 ).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in Figures S4a\u2013d.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}